Legend Biotech (LEGN) EPS (Basic) (2019 - 2025)
Legend Biotech (LEGN) reported EPS (Basic) of $0.0 for Q4 2025, up 104.24% on a YoY basis from $0.0 in Q4 2024, and up 100.0% quarter-over-quarter from -$1.04 in Q3 2025.
Legend Biotech (LEGN) EPS (Basic) (2019 - 2025) Analysis & Trends
Legend Biotech has reported EPS (Basic) for 7 years, with the latest figure at $0.0 in Q4 2025.
- For the quarter ending Q4 2025, EPS (Basic) rose 104.24% year-over-year to $0.0; the trailing twelve-month figure through Dec 2025 stood at -$200349.7 (down 2242517.52% YoY), and the FY2025 full-year result was $0.0, up 100.07% from the prior year.
- EPS (Basic) for Q4 2025 stood at $0.0, up from -$1.04 in the prior quarter.
- The five-year high for EPS (Basic) was $0.0 in Q4 2025, with the low at -$200348.4 in Q2 2025.
- Historically, EPS (Basic) has averaged -$10141.8 across 5 years, with a median of -$1.04 in 2022.
- The largest YoY upside for EPS (Basic) was 104.24% in 2025 against a maximum downside of 3722576.03% in 2025.
- Legend Biotech's EPS (Basic) stood at -$0.36 in 2021, then dropped by 18.66% to -$0.43 in 2022, then sank by 575691.7% to -$2459.6 in 2023, then soared by 100.0% to -$0.0 in 2024, then jumped by 104.24% to $0.0 in 2025.
- The last three EPS (Basic) figures came in at $0.0 (Q4 2025), -$1.04 (Q3 2025), and -$200348.4 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 6.99 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | -1.04 |
| Jun 30, 2025 | -200,348.39 |
| Mar 31, 2025 | -0.27 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | -3.39 |
| Jun 30, 2024 | -5.38 |
| Mar 31, 2024 | -0.16 |
| Dec 31, 2023 | -2,459.61 |
| Sep 30, 2023 | -1.73 |
| Jun 30, 2023 | -5.53 |
| Mar 31, 2023 | -3.40 |
| Dec 31, 2022 | -0.43 |
| Sep 30, 2022 | -0.26 |
| Jun 30, 2022 | -0.62 |
| Mar 31, 2022 | -1.04 |
| Dec 31, 2021 | -0.36 |
| Sep 30, 2021 | -1.70 |
| Jun 30, 2021 | -3.16 |
| Mar 31, 2021 | -0.34 |